My people, e no go believe wetin I go yarn for here. Biopharma sector don turn ground for gbege as plenty companies dey chop layoffs like say dem dey share suya for street. From Nido Biosciences wey wan shut down, to Pfizer wey carry more than 200 pipo go waka, the level don dey serious!

First off, Nido Biosciences wey dey Massachusetts don announce sey dem go close shop early dis year. Dem no even talk how many workers go japa, but e fit be sey na small crew dey for there. Na the Phase II clinical trial wey dem dey run for one kind drug wey dem name NIDO-361 fall flat, so dem gats pack dem load.

Then we get Voyager Therapeutics wey don cut 30 staff after dem partner Novartis drop two programs wey dem dey work on together. Na wah o! This one no clear for dem how much money dem go save but for last year, dem get about 172 workers. Novartis don dash dem $100 million up front, but since dem dey lose ground, dem come dey twiddle dem thumb.

For Intercept Pharmaceuticals, dem don lay off 146 workers after dem product Ocaliva for liver no meet standard. E be like sey dis Ocaliva dey get wahala from FDA, dey reject am like sey na bad jollof rice. People wey wan work for dem na 2026 na him dem go finish layoff.

Mythic Therapeutics join the party too. Dem don throw away dem last clinical trial because fund no dey follow dem. CEO George Eliades yarn say dem don try find money to push dem work but no level. Dem dey sell dem assets now.

Geron Corporation dey try ginger dem sales for Rytelo wey be cancer therapy, so na why dem go sack one-third of dem people. E get as e be, since dem no fit make waves with the drug. Pfizer dey try balance everything, and na why 200 people dey waka from Switzerland camp. Meanwhile, otondo dey cut 2,000 workers since last year across their global operations.

Omo Naija! Na wetin dem dey call ‘strategic realignment’ dem dey do as dem dey fire plenty workers say make dem save cost. E get as e be o. Who go fit see chop for dis matter wey biopharma dey face! Some even say 2026 fit too far o!

Valneva dey close down for France, dem no go yarn how severance go be for 30 workers dey go home. Novartis dey cut 550 full-time jobs. Omo! Dis one be like say dem wan turn the industry into ghost town.

The palava for biopharma no be small o! When una hear all dis cuts, e go make you wonder wetin dey happen for industry. Abeg, make dem find solution to dis wahala. We sabi sey no easy, but make dem try manage dem workforce well. Na wetin dey important be that!